Discontinuation report NUCALA
| Report ID | 212755 |
| Drug Identification Number | 02449781 |
| Brand name | NUCALA |
| Common or Proper name | Mepolizumab for Injection |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | MEPOLIZUMAB |
| Strength(s) | 100MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 1x10mL |
| ATC code | R03DX |
| ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2023-12-06 |
| Remaining supply date | 2027-06-12 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Autoinjector and Pre-Filled Safety Syringe formats are available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2023-12-07 | French | Compare |
| v1 | 2023-12-07 | English | Compare |
Showing 1 to 2 of 2